Location History:
- La Jolla, CA (US) (2020)
- San Diego, CA (US) (2022)
Company Filing History:
Years Active: 2020-2022
Title: Reto Andreas Gadient: Innovator in Metabotropic Glutamate Receptor Modulation
Introduction
Reto Andreas Gadient is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of metabotropic glutamate receptor negative allosteric modulators (NAMs). With a total of 2 patents, his work has the potential to impact therapeutic approaches for various neurological conditions.
Latest Patents
Gadient's latest patents focus on small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs). These patents detail the compounds, compositions, and methods of using these innovative modulators. The implications of his research could lead to advancements in treating disorders related to glutamate signaling.
Career Highlights
Reto Andreas Gadient is affiliated with the Sanford Burnham Prebys Medical Discovery Institute, where he conducts his research. His work is characterized by a commitment to understanding and manipulating receptor activity to develop new therapeutic strategies.
Collaborations
Gadient collaborates with esteemed colleagues such as Nicholas David Peter Cosford and Dhanya Raveendra-Panickar. These partnerships enhance the research environment and foster innovation in their shared field of study.
Conclusion
Reto Andreas Gadient's contributions to the field of pharmacology through his patents on metabotropic glutamate receptor modulators highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in neuroscience.